<DOC>
	<DOCNO>NCT00347698</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy 2.5 mg intravitreal bevacizumab one eye , versus panretinal photocoagulation contralateral eye , treatment patient untreated symmetric proliferative diabetic retinopathy .</brief_summary>
	<brief_title>Intravitreal Bevacizumab Vs Photocoagulation Proliferative Diabetic Retinopathy</brief_title>
	<detailed_description>The current gold standard treatment proliferative diabetic retinopathy panretinal photocoagulation . However , treatment result significant discomfort patient , cause reduction visual acuity visual field impairment . Intravitreal bevacizumab novel treatment reduces intraocular VEGF concentration therefore inhibit neovascular proliferation , without cause significant disconfort patient , affect visual acuity visual field ( although risk associate intravitreal injection ) . Making comparison treatment different patient difficult variable influence progression disease ( glycemic control renal insufficiency ) . Therefore study design use treatment patient : intravitreal bevacizumab one eye , compare panretinal photocoagulation contralateral eye , evaluate visual acuity , visual field , fluorescein angiography , optic coherence tomography macula , patient discomfort , one-year follow-up .</detailed_description>
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>symmetric proliferative diabetic retinopathy without high risk characteristic age 18 year old patient consent heart attack cerebrovascular attack eye retinal detachment vitreous haemorrhage previous treatment diabetic retinopathy medium opacity preclude visualization fundus pregnancy inability understand implication protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2006</verification_date>
	<keyword>diabetic retinopathy</keyword>
	<keyword>bevacizumab</keyword>
	<keyword>photocoagulation</keyword>
</DOC>